According to the research report the global market for Oral Blood Glucose Regulators should grow from US$ 61200 million in 2022 to US$ 131610 million by 2029, with a CAGR of 12.7% for the period of 2023-2029.
China Oral Blood Glucose Regulators market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Oral Blood Glucose Regulators market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Biguanides segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Oral Blood Glucose Regulators include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Oral Blood Glucose Regulators are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report aims to provide a comprehensive study of the global market for Oral Blood Glucose Regulators.
Report Highlights:
(1) Global Oral Blood Glucose Regulators market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Oral Blood Glucose Regulators market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Oral Blood Glucose Regulators market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Oral Blood Glucose Regulators segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Oral Blood Glucose Regulators segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Oral Blood Glucose Regulators, capacity, production and trends.
(7) Oral Blood Glucose Regulators industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Biguanides
Sulfonylureas
Meglitinides
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
SGLT2 Inhibitors
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Other
Market segment by application, can be divided into
Hospital
Clinic
Other
Market segment by players, this report covers
Bayer
Merck
Novartis
Huadong Medicine
Sanofi
Novo Nordisk
Servier
Takeda Pharmaceutical
Luye Pharmaceutical
Taiji Group
CR Double-Crane
AstraZeneca
Boehringer Ingelheim
Qilu Pharmaceutical
Jiangsu Deyuan Pharmaceutical
CTTQ
1 Market Overview
1.1 Oral Blood Glucose Regulators Definition
1.2 Global Oral Blood Glucose Regulators Market Size and Forecast
1.2.1 By Revenue, Global Oral Blood Glucose Regulators Market Size, 2018-2029
1.2.2 By Sales Volume, Global Oral Blood Glucose Regulators Market Size, 2018-2029
1.2.3 Global Oral Blood Glucose Regulators Price Trend, 2018-2029
1.3 China Oral Blood Glucose Regulators Market Size and Forecast
1.3.1 By Revenue, China Oral Blood Glucose Regulators Market Size, 2018-2029
1.3.2 By Sales Volume, China Oral Blood Glucose Regulators Market Size, 2018-2029
1.3.3 China Oral Blood Glucose Regulators Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Oral Blood Glucose Regulators Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Oral Blood Glucose Regulators Share in Global Market, 2018-2029
1.4.3 Oral Blood Glucose Regulators Market Size: China VS Global, 2018-2029
1.5 Oral Blood Glucose Regulators Market Dynamics
1.5.1 Oral Blood Glucose Regulators Market Drivers
1.5.2 Oral Blood Glucose Regulators Market Restraints
1.5.3 Oral Blood Glucose Regulators Industry Trends
1.5.4 Oral Blood Glucose Regulators Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Oral Blood Glucose Regulators Revenue by Company, 2018-2023
2.2 Global Oral Blood Glucose Regulators Sales Volume by Company, 2018-2023
2.3 Global Oral Blood Glucose Regulators Price by Company, 2018-2023
2.4 Global Oral Blood Glucose Regulators Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Oral Blood Glucose Regulators Concentration Ratio
2.6 Global Oral Blood Glucose Regulators Mergers & Acquisitions, Expansion Plans
2.7 Global Oral Blood Glucose Regulators Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Oral Blood Glucose Regulators Revenue by Company, 2018-2023
3.2 China Oral Blood Glucose Regulators Sales Volume by Company, 2018-2023
3.3 China Oral Blood Glucose Regulators Oral Blood Glucose Regulators Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Oral Blood Glucose Regulators Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Oral Blood Glucose Regulators Domestic VS Export
3.6 China Market, Oral Blood Glucose Regulators Import & Export
3.6.1 China Market, Oral Blood Glucose Regulators Import & Export, 2018-2029
3.6.2 China Oral Blood Glucose Regulators Import & Export Trends
3.6.3 Main Sources of China Oral Blood Glucose Regulators Import
3.6.4 Export Destination of China Oral Blood Glucose Regulators
4 Oral Blood Glucose Regulators Production by Region
4.1 Global Oral Blood Glucose Regulators Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Oral Blood Glucose Regulators Manufacturers
4.3 Global Major Manufacturers, Oral Blood Glucose Regulators Capacity Expansion and Future Plans
4.4 Global Oral Blood Glucose Regulators Capacity by Region
4.5 Global Oral Blood Glucose Regulators Production by Region
4.5.1 Global Oral Blood Glucose Regulators Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Oral Blood Glucose Regulators Production by Region, 2018-2023
4.5.3 Global Oral Blood Glucose Regulators Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Oral Blood Glucose Regulators Industry Chain
5.2 Oral Blood Glucose Regulators Upstream Analysis
5.2.1 Oral Blood Glucose Regulators Core Raw Materials
5.2.2 Main Manufacturers of Oral Blood Glucose Regulators Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Oral Blood Glucose Regulators Production Mode
5.6 Oral Blood Glucose Regulators Procurement Model
5.7 Oral Blood Glucose Regulators Industry Sales Model and Sales Channels
5.7.1 Oral Blood Glucose Regulators Sales Model
5.7.2 Oral Blood Glucose Regulators Typical Distributors
6 Sights by Type
6.1 Oral Blood Glucose Regulators Classification
6.1.1 Biguanides
6.1.2 Sulfonylureas
6.1.3 Meglitinides
6.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
6.1.5 SGLT2 Inhibitors
6.1.6 Thiazolidinediones
6.1.7 Alpha-Glucosidase Inhibitors
6.1.8 Other
6.2 By Type, Global Oral Blood Glucose Regulators Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Oral Blood Glucose Regulators Revenue, 2018-2029
6.4 By Type, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029
6.5 By Type, Global Oral Blood Glucose Regulators Price, 2018-2029
7 Sights by Application
7.1 Oral Blood Glucose Regulators Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 By Application, Global Oral Blood Glucose Regulators Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Oral Blood Glucose Regulators Revenue, 2018-2029
7.4 By Application, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029
7.5 By Application, Global Oral Blood Glucose Regulators Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Oral Blood Glucose Regulators Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Oral Blood Glucose Regulators Revenue, 2018-2029
8.3 By Region, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Oral Blood Glucose Regulators Market Size Market Share
8.5 Europe
8.5.1 Europe Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Oral Blood Glucose Regulators Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Oral Blood Glucose Regulators Market Size Market Share
8.7 South America
8.7.1 South America Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Oral Blood Glucose Regulators Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Oral Blood Glucose Regulators Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Oral Blood Glucose Regulators Revenue, 2018-2029
9.3 By Country, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Oral Blood Glucose Regulators Market Size, 2018-2029
9.4.2 By Company, U.S. Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Oral Blood Glucose Regulators Market Size, 2018-2029
9.5.2 By Company, Europe Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.5.3 By Type, Europe Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Oral Blood Glucose Regulators Market Size, 2018-2029
9.6.2 By Company, China Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.6.3 By Type, China Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Oral Blood Glucose Regulators Market Size, 2018-2029
9.7.2 By Company, Japan Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.7.3 By Type, Japan Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Oral Blood Glucose Regulators Market Size, 2018-2029
9.8.2 By Company, South Korea Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Oral Blood Glucose Regulators Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Oral Blood Glucose Regulators Market Size, 2018-2029
9.10.2 By Company, India Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.10.3 By Type, India Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Oral Blood Glucose Regulators Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Oral Blood Glucose Regulators Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bayer
10.1.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.1.2 Bayer Oral Blood Glucose Regulators Models, Specifications and Application
10.1.3 Bayer Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bayer Company Profile and Main Business
10.1.5 Bayer Recent Developments
10.2 Merck
10.2.1 Merck Company Information, Head Office, Market Area and Industry Position
10.2.2 Merck Oral Blood Glucose Regulators Models, Specifications and Application
10.2.3 Merck Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck Company Profile and Main Business
10.2.5 Merck Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.3.2 Novartis Oral Blood Glucose Regulators Models, Specifications and Application
10.3.3 Novartis Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 Huadong Medicine
10.4.1 Huadong Medicine Company Information, Head Office, Market Area and Industry Position
10.4.2 Huadong Medicine Oral Blood Glucose Regulators Models, Specifications and Application
10.4.3 Huadong Medicine Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Huadong Medicine Company Profile and Main Business
10.4.5 Huadong Medicine Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.5.2 Sanofi Oral Blood Glucose Regulators Models, Specifications and Application
10.5.3 Sanofi Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
10.6.2 Novo Nordisk Oral Blood Glucose Regulators Models, Specifications and Application
10.6.3 Novo Nordisk Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Novo Nordisk Company Profile and Main Business
10.6.5 Novo Nordisk Recent Developments
10.7 Servier
10.7.1 Servier Company Information, Head Office, Market Area and Industry Position
10.7.2 Servier Oral Blood Glucose Regulators Models, Specifications and Application
10.7.3 Servier Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Servier Company Profile and Main Business
10.7.5 Servier Recent Developments
10.8 Takeda Pharmaceutical
10.8.1 Takeda Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.8.2 Takeda Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
10.8.3 Takeda Pharmaceutical Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Takeda Pharmaceutical Company Profile and Main Business
10.8.5 Takeda Pharmaceutical Recent Developments
10.9 Luye Pharmaceutical
10.9.1 Luye Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Luye Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
10.9.3 Luye Pharmaceutical Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Luye Pharmaceutical Company Profile and Main Business
10.9.5 Luye Pharmaceutical Recent Developments
10.10 Taiji Group
10.10.1 Taiji Group Company Information, Head Office, Market Area and Industry Position
10.10.2 Taiji Group Oral Blood Glucose Regulators Models, Specifications and Application
10.10.3 Taiji Group Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Taiji Group Company Profile and Main Business
10.10.5 Taiji Group Recent Developments
10.11 CR Double-Crane
10.11.1 CR Double-Crane Company Information, Head Office, Market Area and Industry Position
10.11.2 CR Double-Crane Oral Blood Glucose Regulators Models, Specifications and Application
10.11.3 CR Double-Crane Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 CR Double-Crane Company Profile and Main Business
10.11.5 CR Double-Crane Recent Developments
10.12 AstraZeneca
10.12.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.12.2 AstraZeneca Oral Blood Glucose Regulators Models, Specifications and Application
10.12.3 AstraZeneca Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 AstraZeneca Company Profile and Main Business
10.12.5 AstraZeneca Recent Developments
10.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.13.2 Boehringer Ingelheim Oral Blood Glucose Regulators Models, Specifications and Application
10.13.3 Boehringer Ingelheim Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Boehringer Ingelheim Company Profile and Main Business
10.13.5 Boehringer Ingelheim Recent Developments
10.14 Qilu Pharmaceutical
10.14.1 Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.14.2 Qilu Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
10.14.3 Qilu Pharmaceutical Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Qilu Pharmaceutical Company Profile and Main Business
10.14.5 Qilu Pharmaceutical Recent Developments
10.15 Jiangsu Deyuan Pharmaceutical
10.15.1 Jiangsu Deyuan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
10.15.3 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Jiangsu Deyuan Pharmaceutical Company Profile and Main Business
10.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments
10.16 CTTQ
10.16.1 CTTQ Company Information, Head Office, Market Area and Industry Position
10.16.2 CTTQ Oral Blood Glucose Regulators Models, Specifications and Application
10.16.3 CTTQ Oral Blood Glucose Regulators Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CTTQ Company Profile and Main Business
10.16.5 CTTQ Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Oral Blood Glucose Regulators Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oral Blood Glucose Regulators Market Restraints
Table 3. Oral Blood Glucose Regulators Market Trends
Table 4. Oral Blood Glucose Regulators Industry Policy
Table 5. Global Oral Blood Glucose Regulators Revenue by Company, 2018-2023, US$ million
Table 6. Global Oral Blood Glucose Regulators Revenue Market Share by Company, 2018-2023
Table 7. Global Oral Blood Glucose Regulators Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Oral Blood Glucose Regulators Sales Volume Market Share by Company, 2018-2023
Table 9. Global Oral Blood Glucose Regulators Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Oral Blood Glucose Regulators Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Oral Blood Glucose Regulators Mergers & Acquisitions, Expansion Plans
Table 12. Global Oral Blood Glucose Regulators Manufacturers Product Type
Table 13. China Oral Blood Glucose Regulators Revenue by Company, 2018-2023, US$ million
Table 14. China Oral Blood Glucose Regulators Revenue Market Share by Company, 2018-2023
Table 15. China Oral Blood Glucose Regulators Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Oral Blood Glucose Regulators Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Oral Blood Glucose Regulators Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Oral Blood Glucose Regulators Import & Export Trends
Table 19. Main Sources of China Oral Blood Glucose Regulators Import
Table 20. Export Destination of China Oral Blood Glucose Regulators
Table 21. Global Headquarters and Manufacturing Base of Oral Blood Glucose Regulators Manufacturers
Table 22. Global Major Manufacturers, Oral Blood Glucose Regulators Capacity Expansion and Future Plans
Table 23. Global Oral Blood Glucose Regulators Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Oral Blood Glucose Regulators Production by Region, 2018-2023, (K Units)
Table 25. Global Oral Blood Glucose Regulators Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Oral Blood Glucose Regulators Upstream (Raw Materials)
Table 27. Global Oral Blood Glucose Regulators Typical Customers
Table 28. Oral Blood Glucose Regulators Typical Distributors
Table 29. By Type, Global Oral Blood Glucose Regulators Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Oral Blood Glucose Regulators Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Oral Blood Glucose Regulators Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Oral Blood Glucose Regulators Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Oral Blood Glucose Regulators Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Oral Blood Glucose Regulators Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Oral Blood Glucose Regulators Revenue Market Share, 2018-2029
Table 37. By Country, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Oral Blood Glucose Regulators Sales Volume Market Share, 2018-2029
Table 39. Bayer Company Information, Head Office, Market Area and Industry Position
Table 40. Bayer Oral Blood Glucose Regulators Models, Specifications and Application
Table 41. Bayer Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Bayer Company Profile and Main Business
Table 43. Bayer Recent Developments
Table 44. Merck Company Information, Head Office, Market Area and Industry Position
Table 45. Merck Oral Blood Glucose Regulators Models, Specifications and Application
Table 46. Merck Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck Company Profile and Main Business
Table 48. Merck Recent Developments
Table 49. Novartis Company Information, Head Office, Market Area and Industry Position
Table 50. Novartis Oral Blood Glucose Regulators Models, Specifications and Application
Table 51. Novartis Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis Company Profile and Main Business
Table 53. Novartis Recent Developments
Table 54. Huadong Medicine Company Information, Head Office, Market Area and Industry Position
Table 55. Huadong Medicine Oral Blood Glucose Regulators Models, Specifications and Application
Table 56. Huadong Medicine Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Huadong Medicine Company Profile and Main Business
Table 58. Huadong Medicine Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 60. Sanofi Oral Blood Glucose Regulators Models, Specifications and Application
Table 61. Sanofi Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Novo Nordisk Company Information, Head Office, Market Area and Industry Position
Table 65. Novo Nordisk Oral Blood Glucose Regulators Models, Specifications and Application
Table 66. Novo Nordisk Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Novo Nordisk Company Profile and Main Business
Table 68. Novo Nordisk Recent Developments
Table 69. Servier Company Information, Head Office, Market Area and Industry Position
Table 70. Servier Oral Blood Glucose Regulators Models, Specifications and Application
Table 71. Servier Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Servier Company Profile and Main Business
Table 73. Servier Recent Developments
Table 74. Takeda Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 75. Takeda Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
Table 76. Takeda Pharmaceutical Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Takeda Pharmaceutical Company Profile and Main Business
Table 78. Takeda Pharmaceutical Recent Developments
Table 79. Luye Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Luye Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
Table 81. Luye Pharmaceutical Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Luye Pharmaceutical Company Profile and Main Business
Table 83. Luye Pharmaceutical Recent Developments
Table 84. Taiji Group Company Information, Head Office, Market Area and Industry Position
Table 85. Taiji Group Oral Blood Glucose Regulators Models, Specifications and Application
Table 86. Taiji Group Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Taiji Group Company Profile and Main Business
Table 88. Taiji Group Recent Developments
Table 89. CR Double-Crane Company Information, Head Office, Market Area and Industry Position
Table 90. CR Double-Crane Oral Blood Glucose Regulators Models, Specifications and Application
Table 91. CR Double-Crane Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. CR Double-Crane Company Profile and Main Business
Table 93. CR Double-Crane Recent Developments
Table 94. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 95. AstraZeneca Oral Blood Glucose Regulators Models, Specifications and Application
Table 96. AstraZeneca Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. AstraZeneca Company Profile and Main Business
Table 98. AstraZeneca Recent Developments
Table 99. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 100. Boehringer Ingelheim Oral Blood Glucose Regulators Models, Specifications and Application
Table 101. Boehringer Ingelheim Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Boehringer Ingelheim Company Profile and Main Business
Table 103. Boehringer Ingelheim Recent Developments
Table 104. Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 105. Qilu Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
Table 106. Qilu Pharmaceutical Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Qilu Pharmaceutical Company Profile and Main Business
Table 108. Qilu Pharmaceutical Recent Developments
Table 109. Jiangsu Deyuan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Models, Specifications and Application
Table 111. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Jiangsu Deyuan Pharmaceutical Company Profile and Main Business
Table 113. Jiangsu Deyuan Pharmaceutical Recent Developments
Table 114. CTTQ Company Information, Head Office, Market Area and Industry Position
Table 115. CTTQ Oral Blood Glucose Regulators Models, Specifications and Application
Table 116. CTTQ Oral Blood Glucose Regulators Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. CTTQ Company Profile and Main Business
Table 118. CTTQ Recent Developments
List of Figure
Figure 1. Oral Blood Glucose Regulators Picture
Figure 2. By Revenue, Global Oral Blood Glucose Regulators Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Oral Blood Glucose Regulators Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Oral Blood Glucose Regulators Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Oral Blood Glucose Regulators Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Oral Blood Glucose Regulators Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Oral Blood Glucose Regulators Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Oral Blood Glucose Regulators Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Oral Blood Glucose Regulators Share of Global Market, 2018-2029
Figure 10. Global Oral Blood Glucose Regulators Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Oral Blood Glucose Regulators Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Oral Blood Glucose Regulators Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Oral Blood Glucose Regulators Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Oral Blood Glucose Regulators Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Oral Blood Glucose Regulators Domestic VS Export, 2022
Figure 16. Global Oral Blood Glucose Regulators Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Oral Blood Glucose Regulators Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Oral Blood Glucose Regulators Production Market Share & Forecast by Region, 2018-2029
Figure 19. Oral Blood Glucose Regulators Industry Chain
Figure 20. Oral Blood Glucose Regulators Procurement Model
Figure 21. Oral Blood Glucose Regulators Sales Model
Figure 22. Oral Blood Glucose Regulators Sales Channels, Direct Sales and Distribution
Figure 23. Biguanides
Figure 24. Sulfonylureas
Figure 25. Meglitinides
Figure 26. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 27. SGLT2 Inhibitors
Figure 28. Thiazolidinediones
Figure 29. Alpha-Glucosidase Inhibitors
Figure 30. Other
Figure 31. By Type, Global Oral Blood Glucose Regulators Revenue, 2018-2029, US$ Million
Figure 32. By Type, Global Oral Blood Glucose Regulators Revenue Market Share, 2018-2029
Figure 33. By Type, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 34. By Type, Global Oral Blood Glucose Regulators Sales Volume Market Share, 2018-2029
Figure 35. By Type, Global Oral Blood Glucose Regulators Price, 2018-2029, (US$/Unit)
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Other
Figure 39. By Application, Global Oral Blood Glucose Regulators Revenue, 2018-2029, US$ Million
Figure 40. By Application, Global Oral Blood Glucose Regulators Revenue Market Share, 2018-2029
Figure 41. By Application, Global Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 42. By Application, Global Oral Blood Glucose Regulators Sales Volume Market Share, 2018-2029
Figure 43. By Application, Global Oral Blood Glucose Regulators Price, 2018-2029, (US$/Unit)
Figure 44. By Region, Global Oral Blood Glucose Regulators Revenue Market Share, 2018-2029
Figure 45. By Region, Global Oral Blood Glucose Regulators Sales Volume Market Share, 2018-2029
Figure 46. North America Oral Blood Glucose Regulators Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, North America Oral Blood Glucose Regulators Revenue Market Share, 2022
Figure 48. Europe Oral Blood Glucose Regulators Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, Europe Oral Blood Glucose Regulators Revenue Market Share, 2022
Figure 50. Asia Pacific Oral Blood Glucose Regulators Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country/Region, Asia Pacific Oral Blood Glucose Regulators Revenue Market Share, 2022
Figure 52. South America Oral Blood Glucose Regulators Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. By Country, South America Oral Blood Glucose Regulators Revenue Market Share, 2022
Figure 54. Middle East & Africa Oral Blood Glucose Regulators Revenue & Forecasts, 2018-2029, US$ Million
Figure 55. U.S. Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, U.S. Oral Blood Glucose Regulators Market Share, 2022
Figure 57. By Type, U.S. Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, U.S. Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 59. Europe Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, Europe Oral Blood Glucose Regulators Market Share, 2022
Figure 61. By Type, Europe Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, Europe Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 63. China Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, China Oral Blood Glucose Regulators Market Share, 2022
Figure 65. By Type, China Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, China Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 67. Japan Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, Japan Oral Blood Glucose Regulators Market Share, 2022
Figure 69. By Type, Japan Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, Japan Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 71. South Korea Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, South Korea Oral Blood Glucose Regulators Market Share, 2022
Figure 73. By Type, South Korea Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, South Korea Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 75. Southeast Asia Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, Southeast Asia Oral Blood Glucose Regulators Market Share, 2022
Figure 77. By Type, Southeast Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, Southeast Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 79. India Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, India Oral Blood Glucose Regulators Market Share, 2022
Figure 81. By Type, India Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, India Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 83. Middle East & Asia Oral Blood Glucose Regulators Sales Volume, 2018-2029, (K Units)
Figure 84. By Company, Middle East & Asia Oral Blood Glucose Regulators Market Share, 2022
Figure 85. By Type, Middle East & Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 86. By Application, Middle East & Asia Oral Blood Glucose Regulators Sales Volume Market Share, 2022 VS 2029
Figure 87. Research Methodology
Figure 88. Breakdown of Primary Interviews
Figure 89. Bottom-up Approaches
Figure 90. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|